- Home
- GMM vs SRZN Comparison
GMM vs SRZN Comparison
Compare GMM & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- SRZN
- Stock Information
- Founded
- GMM 2017
- SRZN 2015
- Country
- GMM China
- SRZN United States
- Employees
- GMM N/A
- SRZN N/A
- Industry
- GMM
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- GMM
- SRZN Health Care
- Exchange
- GMM Nasdaq
- SRZN Nasdaq
- Market Cap
- GMM 61.9M
- SRZN 72.8M
- IPO Year
- GMM 2023
- SRZN N/A
- Fundamental
- Price
- GMM $2.61
- SRZN $9.39
- Analyst Decision
- GMM
- SRZN Strong Buy
- Analyst Count
- GMM 0
- SRZN 2
- Target Price
- GMM N/A
- SRZN $38.50
- AVG Volume (30 Days)
- GMM 20.8K
- SRZN 9.4K
- Earning Date
- GMM 08-08-2025
- SRZN 08-11-2025
- Dividend Yield
- GMM N/A
- SRZN N/A
- EPS Growth
- GMM 62.17
- SRZN N/A
- EPS
- GMM 6.37
- SRZN N/A
- Revenue
- GMM $41,360,953.00
- SRZN $11,638,000.00
- Revenue This Year
- GMM N/A
- SRZN N/A
- Revenue Next Year
- GMM N/A
- SRZN N/A
- P/E Ratio
- GMM $0.41
- SRZN N/A
- Revenue Growth
- GMM 53.82
- SRZN N/A
- 52 Week Low
- GMM $1.69
- SRZN $5.90
- 52 Week High
- GMM $15.60
- SRZN $27.75
- Technical
- Relative Strength Index (RSI)
- GMM 42.90
- SRZN 62.73
- Support Level
- GMM $2.53
- SRZN $8.20
- Resistance Level
- GMM $3.09
- SRZN $9.50
- Average True Range (ATR)
- GMM 0.25
- SRZN 0.52
- MACD
- GMM -0.02
- SRZN 0.10
- Stochastic Oscillator
- GMM 12.82
- SRZN 91.30
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).